Association for Research in Vision and Ophthalmology
Association for Research in Vision and Ophthalmology
May 24, 2017
1 min watch
Save

VIDEO: Ozurdex reduces ischemia in diabetic retinopathy in pilot study

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

BALTIMORE ― At the Association for Research in Vision and Ophthalmology meeting here, Giuseppe Querques, MD, PhD, discusses a pilot study of Ozurdex (Allergan) in the reduction of ischemia in patients with diabetic retinopathy. Querques reports a three-fold reduction in eyes treated with intravitreal steroids in the eyes studied.